You may recall that we recently went on a UKTI Trade mission trip to Los Angeles to better understand the potential of the US market. Hardly a ‘normal’ week for us, but we managed to capture events as we went along and here is our summary of a fantastic adventure that worked out really well for us and certainly raised our profile! Anyone that would like a job – ‘please apply within’ Chris

My Week: Chris Penfold, of Design Cognition

Published – Tuesday, November 24, 2009, from www.thisisbusiness-eastmidlands.co.uk/

Friday: Our company, Design Cognition, provides packing development and consultancy services to the pharmaceutical industry.

We have been thinking about exporting our skills and services to the US, which represents 40% of the global healthcare market, so a trade mission to the American Association of Pharmaceutical Scientists convention in Los Angeles seems an ideal route in.

Through UKTI, we manage to secure a free Club Class flight with BA – sadly only one. I fly ‘cattle class’ whilst our chief technical officer Annie Dallison enjoys the Club lounge, Champagne reception and a top-of-the-range bed. I sit with my bag of crisps, a bottle of water and a good book.

Arriving at Los Angeles airport we are greeted by a friendly character who directs us to the hotel shuttle bus and then announces that he is a volunteer collecting for the destitute and homeless of LA. We give him a small donation.

As we enter LA, the problem facing President Obama becomes ever more apparent as we see a number of homeless sleeping rough by the roadside. It’s obvious why donations for the destitute are needed. We certainly take our NHS service for granted. Despite its many faults, we can expect a certain level of care from a system which is the envy of the world.

Saturday: Our hotel is actually a ‘motel’ with a few extras such as a pond for a swimming pool. I get the Jacuzzi in my room and Annie doesn’t, so I feel slightly vindicated after the flight arrangements.

Sunday: After breakfast we catch up with George Canty of the East Midlands Healthcare and Bioscience iNet, who is representing UKTI. He will be helping us to meet potential customers, suppliers and partners and to discuss funding with investors.

We decide to spend today on the Pacific coast at Santa Monica and Venice Beach where tea and cake at the Tudor tea rooms includes a choice of any tea from around the world, including Typhoo and PG Tips.

The afternoon is spent at the LA Convention Centre where we set up the stand for the show.

The trade mission has involved a number of our BioCity Nottingham sister companies including Pharmaceutical Development Services and Food & Drink Analytical Services. We will be sharing stand facilities for the next few days.

This evening UKTI holds a networking meeting at the ‘Scottish Pub’ so we get to know the UKTI representatives in the US.

The team get to meet The British Consul General, Dame Barbara Hay

Monday: Still ‘Sleepless in LA’ with a 4.30am awakening. I’m finding difficulty adjusting to the eight hour time difference, so I use my time productively to catch up on emails and to press my crumpled suit.

The American Association of Pharmaceutical Scientists’ exhibition doesn’t start until 12.30. It is momentarily disrupted by animal rights protestors so security levels are high. The event gets off to a good start and we have a steady stream of visitors to our stand.

The purpose for our being here is to learn as much as possible about the US market and to assess how we might help US pharmaceutical companies to better understand European pharmaceutical packaging requirements and regulations.

Tuesday: A full day at the show is followed by an evening reception hosted by UKTI and the British Consul General, Dame Barbara Hay.

We are on the 54th floor of the Wells Fargo building with fabulous panoramic views of illuminated LA. Today is my 50th birthday so it is great to celebrate in style.

In a quieter moment we get to meet Samuel L Jackson

Wednesday

I manage to sleep in until 5am as my body continues to adjust. The third day and climax of the show is slower but we attract some potential leads.

Thursday

We leave for England today and everything seems to be going according to plan.

Annie makes the most of being amongst the privileged in the Club Class environment whilst I have another sandwich. Our expectations for this trip had been modest and we hadn’t expected to come back with a ‘shed full’ of orders, but we both agree that the trip has been invaluable.

You can read the ‘This is Business’ article here: LA Article

The internet is ‘afrenzy’ at the moment with stories relating to a possible sale or merger of Reckitt Benckiser. We’ve picked it up here from a couple of sources which contradict each other slightly, but this is not surprising and is normal in any takeover/merger rumour situatuion. SSL International and Colgate-Palmolive are both ‘in the frame’ (allegedly), but it’s not clear who’s buying whom or what (guess that they could also be considering buying & selling business divisons or brands). We will let you read them and make up your own mind. Chris

Rumours fly over sale or merger of Reckitt Benckiser

Simon Pitman, Cosmetics Design-Europe.com 19 Nov 2009

Talk of a multi-billion euro transaction involving Reckitt Benckiser, a global brand owner of personal care and household products, has sent share prices rocketing.

The UK company has been linked to big names such as SSL International, owner of the Durex brand, but according to well-placed sources used by British newspaper The Daily Telegraph, the most obvious candidate is US consumer giant Colgate-Palmolive.

The report stated that Reckitt Benckiser was close to making a cross-border transaction that would probably be structured as a merger if it were to take place with a business such as Colgate-Palmolive.

Such a deal would also tie in with the company’s desire to no longer be headquartered in the UK, due to the unfavourable tax situation and economy.

You can read the full Cosmetics Design-Europe article here: http://bit.ly/4B2Uxx

The story has also been covered in the  British press (amongst other places). In yesterday’s UK  Daily Telegraph, they carried the following:

Talk of Reckitt doing a big deal

Ben Harrington, www.telegraph.co.uk, 18 Nov 2009

The latest tale is that Reckitt Benckiser is close to announcing multi-billion pound cross-border transaction.

It is not clear which company Reckitt is targeting. SSL International, the maker of Scholl footwear products and Durex condoms, has always been tipped as a target for Reckitt. However, well-placed sources think the most obvious candidate is US giant Colgate-Palmolive.

The theory is that any deal between Reckitt and Colgate-Palmolive would have to be structured as a merger as they are roughly the same size.

Earlier this year, David Hayes and Alex Smith – the Nomura analysts who first raised the prospect of a Kraft bid for Cadbury – argued that Colgate-Palmolive could merge with a British company. However, they thought it more likely that Unilever would be the US company’s obvious merger partner.

You can read more of the Daily Telegraph report here: http://bit.ly/2GcdEy

This has been reported previously in the press. See related article ‘Reckitt Benckiser considers quitting Britain over tax‘ published in the UK Daily Telegraph 13th Aug 2009.

Whatever, your thoughts, it’s an interesting story that has wide ramifications and we’ll keep you posted as and when updates are available. Chris

NOTTINGHAM science companies will lead a delegation of UK firms pitching for business during one of the biggest events in the American pharmaceutical industry’s calendar.

Businesses from the city account for one-third of the firms in the English delegation attending a reception during the American Association of Pharmaceutical Sciences (AAPS) annual meeting in Los Angeles.

They will meet potential customers and investors next week at an event hosted on their behalf by the British Consul in LA, Dame Barbara Hey.

The Nottingham firms taking part in the 20-strong delegation are Critical Pharmaceuticals, Design Cognition, Food and Drug Analytical Services, Molecular Profiles, Pharmaceutical Development Services and R5 Pharmaceuticals.

The US pharmaceutical market is the biggest and most lucrative in the world, with companies bidding for work in a field where the biggest firms routinely outsource research, development and service work to smaller companies.

Some of the Nottingham firms will be going to link-up with existing contacts, while others, such as specialist packaging and product development firm Design Cognition, are first- timers. Chris Penfold, the company’s chief executive, said: “We are on a fact-finding mission, to learn as much as possible about the US market and assessing where and how we can add value for US pharmaceutical companies looking to export, through our understanding of packaging requirements and regulations of global markets.”

His company is working closely with Pharmaceutical Development Services, which already has an office in the US state of South Carolina, another industry hotspot.

“Making a move into the US requires a great deal of market as well as regulatory intelligence,” said managing director Michael Gamlen.

“Close working relationships and collaboration are key to success and our respective consultancy services dovetail perfectly to add potential value for US companies.”

To read the full article, click here: http://bit.ly/Ox0hr

Watch this space for further information as I will be following up with This is Business- East Midlands (Nottingam Evening Post) after the AAPS event.

NOTTINGHAM science companies will lead a delegation of UK firms pitching for business during one of the biggest events in the American pharmaceutical industry’s calendar.

Businesses from the city account for one-third of the firms in the English delegation attending a reception during the American Association of Pharmaceutical Sciences (AAPS) annual meeting in Los Angeles.

They will meet potential customers and investors next week at an event hosted on their behalf by the British Consul in LA, Dame Barbara Hey.

The Nottingham firms taking part in the 20-strong delegation are Critical Pharmaceuticals, Design Cognition, Food and Drug Analytical Services, Molecular Profiles, Pharmaceutical Development Services and R5 Pharmaceuticals.

The US pharmaceutical market is the biggest and most lucrative in the world, with companies bidding for work in a field where the biggest firms routinely outsource research, development and service work to smaller companies.

Some of the Nottingham firms will be going to link-up with existing contacts, while others, such as specialist packaging and product development firm Design Cognition, are first- timers. Chris Penfold, the company’s chief executive, said: “We are on a fact-finding mission, to learn as much as possible about the US market and assessing where and how we can add value for US pharmaceutical companies looking to export, through our understanding of packaging requirements and regulations of global markets.”

His company is working closely with Pharmaceutical Development Services, which already has an office in the US state of South Carolina, another industry hotspot.

“Making a move into the US requires a great deal of market as well as regulatory intelligence,” said managing director Michael Gamlen.

“Close working relationships and collaboration are key to success and our respective consultancy services dovetail perfectly to add potential value for US companies.”

To read the full article, click here: http://bit.ly/Ox0hr

Watch this space for further information as I will be following up with This is Business- East Midlands (Nottingam Evening Post) after the AAPS event.

Design Cognition are pleased to announce the launch of two new websites that will better meet the evolving needs of our pharmaceutical clients and the wider community in the areas of healthcare packaging design, news & compliance.

FIRSTLY, if you are involved in any way with pharmaceutical packaging design, development or managing pack change, our new healthcare-related blog site www.healthcarepackaging-pulse.com will provide you with a daily snapshot of current news & views from the world of pharmaceutical packaging & affiliated areas – from Rx through OTC, Medical Devices and GSL. Learn from the industry ‘best-in class’.

It will cover creative topics such as design, innovation, and technology,through commercial issues such as cost-optimisation and supply chain performance to regulatory and legislative change affecting the industry.

We hope that you enjoy them and if you are going to AAPS in Los Angeles, November 9th-12th, why not come & visit us at ‘Booth 1962′ to discuss these in more detail? See you there!

Chris Penfold

It has been mandatory to include Braille on all new EU Marketing Authorisations since 30th October 2005.

According to Article 56(a) of Council Directive 2001/83/EC it will be mandatory to include Braille on ALL EU pharmaceutical packaging by October 2010. This includes pharmaceutical products which were launched prior to October 2005.

Braille must show the name of the medicine and the appropriate strength, where more than one strength is available.

Support for Braille introduction
At Design Cognition we take the implementation of Braille very seriously. That is why our Chief Technical Officer Annie Dallison volunteered to be a member of The European Committee for Standardization (CEN) working group on Braille standards. Annie, as a leading industry expert, already had over 8 years of experience in the application of Braille on pharmaceutical packaging developing processes and establishing & setting standards for blue chip companies, making her an ideal member of the working group.

CEN working group
This CEN working group is made up of dedicated representatives from the packaging industry, trade associations, regulatory bodies and blind associations from across Europe.

This group has been working for over 3 years to determine and agree standards, including the Braille font style (Marburg medium) and measurement of Braille cell dot height that can be applied across the whole of the EU. One of the main issues for the team has been reaching agreement on the cell dot height that the blind associations feel will be sufficient to meet the needs of the blind users and also industry believe is commercially achievable. The final standard will hopefully be available before October 2010.

If you’d like find out more and how to avoid breaking the law, get your FREE ‘Introduction to Braille’ follow this link:

http://www.thepharmagateway.com/

If you are going to AAPS in Los Angeles, November 9th-12th, why not come & visit us at ‘Booth 1962′ to discuss this in more detail? See you there!

Chris Penfold